Immune response following intraocular delivery of recombinant viral vectors

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gene Therapy

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302030PMID 12756418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity

  2002cited by this paper
• Phenotypic rescue after adeno‐associated virus‐mediated delivery of 4‐sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI

  2002cited by this paper
• A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus.

  2002cited by this paper
• Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents.

  2002cited by this paper
• Gene transfer mediated by recombinant baculovirus into mouse eye.

  2001cited by this paper
• Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).

  2001cited by this paper
• Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.

  2001cited by this paper
• Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity

  2001cited by this paper
• Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina.

  2001cited by this paper
• Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

  2001cited by this paper
• Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa.

  2001cited by this paper
• Gene therapy restores vision in a canine model of childhood blindness

  2001cited by this paper
• Cross-species comparison of in vivo reporter gene expression after recombinant adeno-associated virus-mediated retinal transduction.

  2000cited by this paper
• Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.

  2000cited by this paper
• Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy

  2000cited by this paper
• Suicide Gene Therapy for Treatment of Retinoblastoma in a Murine Model

  1999cited by this paper
• Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

  1999cited by this paper
• Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV.

  1999cited by this paper
• Herpes simplex virus mediated gene transfer to primate ocular tissues.

  1999cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.

  1998cited by this paper
• The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response

  1998cited by this paper
• Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells.

  1998cited by this paper
• Immune responses limit adenovirally mediated gene expression in the adult mouse eye

  1998cited by this paper
• Analysis of immune deviation elicited by antigens injected into the subretinal space.

  1998cited by this paper
• Gene transfer to ex vivo stored corneas.

  1997cited by this paper
• Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.

  1997cited by this paper
• Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery.

  1997cited by this paper
• Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration

  1997cited by this paper
• Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.

  1997cited by this paper
• Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina

  1997cited by this paper
• The in vivo mechanism of action of CTLA4Ig.

  1996cited by this paper
• Role of Th1 and Th2 cells in anterior chamber‐associated immune deviation

  1996cited by this paper
• Adenovirus-mediated gene delivery to the corneal endothelium.

  1996cited by this paper
• Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy

  1996cited by this paper
• Gene transfer into the mouse retina mediated by an adeno-associated viral vector.

  1996cited by this paper
• Humoral Response after Administration of E1-Deleted Adenoviruses: Immune Privilege of the Subretinal Space

  1996cited by this paper
• Anterograde, transneuronal transport of herpes simplex virus type 1 strain H129 in the murine visual system

  1996cited by this paper
• UNCONVENTIONAL REJECTION OF NEURAL RETINAL ALLOGRAFTS IMPLANTED INTO THE IMMUNOLOGICALLY PRIVILEGED SITE OF THE EYE

  1995cited by this paper
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

  1995cited by this paper
• In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells.

  1995cited by this paper
• Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea.

  1994cited by this paper
• In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector.

  1994cited by this paper
• Adenovirus vector-mediated in vivo gene transfer into adult murine retina.

  1994cited by this paper
• Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor.

  1994cited by this paper
• Differential expression of the complement regulatory proteins in the human eye.

  1993cited by this paper
• Detection of transforming growth factor-alpha messenger RNA and protein in human corneal epithelial cells.

  1992cited by this paper
• Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.

  1991cited by this paper
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper
• Immune regulation and the eye: a dangerous compromise

  1987cited by this paper
• The complement components and their inactivators in the intraocular fluids of the guinea pig.

  1970cited by this paper
• Epidemiology of adenovirus-associated virus infection in a nursery population.

  1968cited by this paper

• Retinoid dynamics in vision: from visual cycle biology to retina disease treatments.

  2025cites this paper
• Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions

  2024cites this paper
• Retention Rates of Genetic Therapies Based on AAV Serotypes 2 and 8 Using Different Drug-Delivery Materials

  2024cites this paper
• Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina

  2024cites this paper
• Clinical and Ocular Inflammatory Inhibitors of Viral-Based Gene Therapy of the Retina

  2024cites this paper
• Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations

  2024cites this paper
• Prominin-1 Knockdown Causes RPE Degeneration in a Mouse Model

  2024cites this paper
• Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration.

  2024cites this paper
• Optimizing Subretinal Bleb Formation for Visual Streak Involvement in a Porcine Model for Retinal Gene Therapy

  2024cites this paper
• Unlocking Genome Editing: Advances and Obstacles in CRISPR/Cas Delivery Technologies

  2024cites this paper
• Delivering large genes using adeno-associated virus and the CRE-lox DNA recombination system

  2024cites this paper
• The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications

  2023influential citation
• OPTH_A_364200 1753..1771

  2022influential citation
• Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses

  2022influential citation
• Ocular Gene Therapy: A Literature Review With Focus on Current Clinical Trials

  2022cites this paper
• A Novel Mouse Model of TGFβ2-Induced Ocular Hypertension Using Lentiviral Gene Delivery

  2022cites this paper
• CRISPR/Cas systems: Delivery and application in gene therapy

  2022cites this paper
• Controlled Subretinal Injection Pressure Prevents Damage in Pigs

  2022cites this paper
• Synergistic gene delivery by self-assembled nanocomplexes using fusion peptide and calcium phosphate.

  2021cites this paper
• The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease

  2021cites this paper
• Chitosan-based polyelectrolyte complexes in biomedical applications

  2021cites this paper
• Nucleic Acid Delivery for Therapeutic Applications.

  2021cites this paper
• Cav1.4 dysfunction and congenital stationary night blindness type 2

  2021cites this paper
• Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration

  2020cites this paper
• Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods.

  2020cites this paper
• Precision Therapy for Inherited Retinal Disease: At the Forefront of Genomic Medicine.

  2020cites this paper
• Viral Delivery Systems for CRISPR

  2019cites this paper
• Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates

  2019cites this paper
• Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges

  2019cites this paper
• Gene Therapy for Inherited Retinal Degeneration

  2019cites this paper
• Immunity to CRISPR Cas9 and Cas12a therapeutics

  2018cites this paper
• Development of safe and efficient aav vectors for retinal gene therapy

  2018cites this paper
• Toll-like receptors 4, 5, 6 and 7 are constitutively expressed in non-human primate retinal neurons.

  2018cites this paper
• Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia

  2018cites this paper
• Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus–Related Toxicity

  2018cites this paper
• Relevance of tissue specific subunit expression in channelopathies.

  2017cites this paper
• Correction of Monogenic and Common Retinal Disorders with Gene Therapy

  2017cites this paper
• Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brains

  2017cites this paper
• Glaucoma Tissue Transglutaminase Elevates Intraocular Pressure in Mice

  2017cites this paper
• Gene therapy for inherited retinal degenerations: initial successes and future challenges

  2017cites this paper
• Feasibility of the functional expression of the human organic anion transporting polypeptide 1B1 (OATP1B1) and its genetic variant 521T/C in the mouse liver

  2017cites this paper
• Tissue Transglutaminase Elevates Intraocular Pressure in Mice.

  2017cites this paper
• Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.

  2017cites this paper
• Gene Manipulation Strategies to Identify Molecular Regulators of Axon Regeneration in the Central Nervous System

  2017cites this paper
• Animal Models of Retinal Degeneration

  2017cites this paper
• Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.

  2017cites this paper
• Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina

  2017cites this paper
• Sobre la terapia génica para enfermedades de la retina

  2017cites this paper
• The Effects of XIAP Gene Therapy in a Murine Model of Leber’s Hereditary Optic Neuropathy and a Feline Model of Retinal Detachment

  2017cites this paper
• Chitosan for DNA and gene therapy

  2017cites this paper
• CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10.

  2017cites this paper
• Inhibition of RelA expression via RNA interference induces immune tolerance in a rat keratoplasty model.

  2016cites this paper
• On Retinal Gene Therapy

  2016cites this paper
• Evaluation of an Optimized Injection System for Retinal Gene Therapy in Human Patients

  2016cites this paper
• Effects of Acute Low-Dose Exposure to the Chlorinated Flame Retardant Dechlorane 602 and Th1 and Th2 Immune Responses in Adult Male Mice

  2016cites this paper
• Primate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-/anti-inflammatory axis.

  2016influential citation
• Let There Be Light: Gene and Cell Therapy for Blindness

  2016cites this paper
• Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid

  2015cites this paper
• AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray

  2015cites this paper
• Preservation of cardiac function in left ventricle cardiac hypertrophy using an AAV vector which provides VEGF-A expression in response to p53.

  2015influential citation
• Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho–/– mouse

  2015cites this paper
• Retinal gene therapy: current progress and future prospects

  2015cites this paper
• An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells

  2015cites this paper
• Nanoparticles for the treatment of ocular neovascularizations.

  2015cites this paper
• Ocular Localization and Transduction by Adenoviral Vectors Are Serotype-Dependent and Can Be Modified by Inclusion of RGD Fiber Modifications

  2014cites this paper
• Electroporating Human Corneal Epithelial Cells With Interleukin 10 and Fas Ligand pDNA

  2014cites this paper
• Vector platforms for gene therapy of inherited retinopathies.

  2014cites this paper
• Clinical applications of retinal gene therapy.

  2013influential citation
• Viral‐Mediated Delivery of shRNA and miRNA

  2013cites this paper
• Inhibition of corneal fibrosis by Smad7 in rats after photorefractive keratectomy.

  2013cites this paper
• Title Expression of an anti-CD4 single chain antibody fragment from the donor cornea can prolong corneal allograft survival in inbred rats Authors

  2013cites this paper
• Grafting zwitterionic polymer chains onto PEI as a convenient strategy to enhance gene delivery performance

  2013cites this paper
• Advances in gene therapy technologies to treat retinitis pigmentosa

  2013cites this paper
• The Liberation of CD44 Intracellular Domain Modulates Adenoviral Vector Transgene Expression*

  2012cites this paper
• Viral Transgene Expression Delivered by Repeat Intraocular Adenoviral Vector Injection: in Vivo Live Imaging Study

  2012cites this paper
• Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid.

  2012cites this paper
• Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.

  2012cites this paper
• Expression of an anti-CD4 single-chain antibody fragment from the donor cornea can prolong corneal allograft survival in inbred rats

  2012cites this paper
• Experimental gene transfer to the corneal endothelium.

  2012cites this paper
• Gene Therapy of Inherited Retinopathies: A Long and Successful Road from Viral Vectors to Patients

  2012cites this paper
• Neovascular Age-Related Macular Degeneration

  2011cites this paper
• Toward advanced modular drug and gene delivery system

  2010cites this paper
• Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies.

  2010cites this paper
• Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats.

  2010cites this paper
• Applications of nanoparticles in ophthalmology.

  2010cites this paper
• Lentivirus‐mediated gene transfer of interleukin 10 to the ovine and human cornea

  2010cites this paper
• Delivery of Helper-dependent Adenoviral Vectors to the Subretinal Space of Mice

  2010cites this paper
• Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation

  2009cites this paper
• Vascular Endothelial Growth Factors In Eye Diseases Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis

  2009cites this paper
• RNA-Interferenz-vermittelte Gentherapie bei Herzinsuffizienz mittels Phospholamban-shRNA exprimierender adenoviraler und AAV–Vektoren

  2009cites this paper
• Lentivirus delivery by adsorption to tissue engineering scaffolds.

  2009cites this paper
• Prospects for genetic modulation of corneal graft survival

  2009cites this paper
• Gene therapy for diseases of the cornea – a review

  2009cites this paper
• Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice

  2009cites this paper
• Immune barriers to successful gene therapy.

  2009cites this paper
• The potential of viral vector-mediated gene transfer to prolong corneal allograft survival.

  2009cites this paper
• A steroid-inducible promoter for the cornea

  2009cites this paper
• Barriers for retinal gene therapy: separating fact from fiction.

  2008cites this paper
• Novel AAV serotypes for improved ocular gene transfer

  2008cites this paper
• Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus.

  2008cites this paper